Sarcopenia prevalence and risk factors in obese Tunisian adults.

Q3 Medicine
Olfa Berriche, Rim Rachdi, Chaima Ammar, Rym Ben Othman, Amel Gamoudi, Henda Jamoussi
{"title":"Sarcopenia prevalence and risk factors in obese Tunisian adults.","authors":"Olfa Berriche, Rim Rachdi, Chaima Ammar, Rym Ben Othman, Amel Gamoudi, Henda Jamoussi","doi":"10.62438/tunismed.v102i8.4965","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Sarcopenia is a clinical condition defined as low skeletal muscle mass and function. It has been identified and described as a geriatric syndrome, but it may arise in individuals with obesity at any age.</p><p><strong>Aim: </strong>screen for sarcopenia in obese adults and identify the nutritional, clinical and biological risk factors associated with the development of sarcopenic obesity (SO+).</p><p><strong>Methods: </strong>Descriptive cross-sectional study, including 53 obese patients. Screening for sarcopenia has been established according to pathological thresholds proposed by the European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO).</p><p><strong>Results: </strong>Mean age was 44.34±13.51 years. Prevalence of Sarcopenia was 7.5% (SO+). The average intakes of calorie, lipids and saturated fatty acids were higher in SO+. A statistically significant relationship was found between low skeletal muscle mass (SMM/W) and the average intake of vitamin PP (p=0.014) and vitamin B9 (p=0.009). Mean BMI (45.86 kg/m² for SO+ versus 39.29 kg/m² for SO-; p=0.03) and mean visceral fat (16.55 l for SO+, versus 10.93 l for SO-; p=0.043) were significantly higher in SO+. A statistically significant relationship was found between insulin resistance and low (SMM/W), as attested by mean insulinemia (28.81 µIU/mL for low SMM/W, versus 14.48 µIU/mL for normal SMM/W; p=0.004) and HOMA index (7.94 for low SMM/W, versus 3.49 for normal SMM/W; p=0.002), which were higher in cases of low (SMM/W).</p><p><strong>Conclusion: </strong>We recommend promoting a balanced, low-energy-density diet to improve insulin sensibility and thus reduce the risk of sarcopenia. Regular physical activity is also strongly recommended.</p>","PeriodicalId":38818,"journal":{"name":"Tunisie Medicale","volume":"102 8","pages":"465-471"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11390009/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tunisie Medicale","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.62438/tunismed.v102i8.4965","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Sarcopenia is a clinical condition defined as low skeletal muscle mass and function. It has been identified and described as a geriatric syndrome, but it may arise in individuals with obesity at any age.

Aim: screen for sarcopenia in obese adults and identify the nutritional, clinical and biological risk factors associated with the development of sarcopenic obesity (SO+).

Methods: Descriptive cross-sectional study, including 53 obese patients. Screening for sarcopenia has been established according to pathological thresholds proposed by the European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO).

Results: Mean age was 44.34±13.51 years. Prevalence of Sarcopenia was 7.5% (SO+). The average intakes of calorie, lipids and saturated fatty acids were higher in SO+. A statistically significant relationship was found between low skeletal muscle mass (SMM/W) and the average intake of vitamin PP (p=0.014) and vitamin B9 (p=0.009). Mean BMI (45.86 kg/m² for SO+ versus 39.29 kg/m² for SO-; p=0.03) and mean visceral fat (16.55 l for SO+, versus 10.93 l for SO-; p=0.043) were significantly higher in SO+. A statistically significant relationship was found between insulin resistance and low (SMM/W), as attested by mean insulinemia (28.81 µIU/mL for low SMM/W, versus 14.48 µIU/mL for normal SMM/W; p=0.004) and HOMA index (7.94 for low SMM/W, versus 3.49 for normal SMM/W; p=0.002), which were higher in cases of low (SMM/W).

Conclusion: We recommend promoting a balanced, low-energy-density diet to improve insulin sensibility and thus reduce the risk of sarcopenia. Regular physical activity is also strongly recommended.

突尼斯肥胖成年人的 "肌少症 "患病率和风险因素。
简介肌肉疏松症是指骨骼肌质量和功能低下的一种临床症状。目的:筛查肥胖成人中的肌肉疏松症,并确定与肌肉疏松性肥胖症(SO+)发展相关的营养、临床和生物学风险因素:方法:描述性横断面研究,包括 53 名肥胖患者。根据欧洲临床营养与代谢学会(ESPEN)和欧洲肥胖症研究协会(EASO)提出的病理阈值,对肌肉疏松症进行筛查:平均年龄为(44.34±13.51)岁。肌肉疏松症患病率为 7.5%(SO+)。SO+人群的卡路里、脂类和饱和脂肪酸平均摄入量较高。低骨骼肌质量(SMM/W)与维生素 PP(p=0.014)和维生素 B9(p=0.009)的平均摄入量之间存在统计学意义上的重大关系。SO+的平均体重指数(SO+为45.86 kg/m²,SO-为39.29 kg/m²;p=0.03)和平均内脏脂肪(SO+为16.55升,SO-为10.93升;p=0.043)显著高于SO+。胰岛素抵抗与低(SMM/W)之间存在统计学意义上的重大关系,这体现在平均胰岛素血症(低SMM/W为28.81 µIU/mL,而正常SMM/W为14.48 µIU/mL;p=0.004)和HOMA指数(低SMM/W为7.94,而正常SMM/W为3.49;p=0.002)上,低(SMM/W)病例的HOMA指数更高:我们建议提倡均衡的低能量密度饮食,以改善胰岛素敏感性,从而降低患肌肉疏松症的风险。我们还强烈建议定期进行体育锻炼。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Tunisie Medicale
Tunisie Medicale Medicine-Medicine (all)
CiteScore
1.00
自引率
0.00%
发文量
72
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信